CN1208075C - Healthy fermentative wine preparation - Google Patents
Healthy fermentative wine preparation Download PDFInfo
- Publication number
- CN1208075C CN1208075C CNB021398739A CN02139873A CN1208075C CN 1208075 C CN1208075 C CN 1208075C CN B021398739 A CNB021398739 A CN B021398739A CN 02139873 A CN02139873 A CN 02139873A CN 1208075 C CN1208075 C CN 1208075C
- Authority
- CN
- China
- Prior art keywords
- radix
- wine
- fermentation
- health care
- flos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title description 3
- 241000628997 Flos Species 0.000 claims abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 12
- 238000000855 fermentation Methods 0.000 claims abstract description 10
- 230000004151 fermentation Effects 0.000 claims abstract description 10
- 230000036541 health Effects 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 9
- 241000005787 Cistanche Species 0.000 claims abstract description 5
- 240000007594 Oryza sativa Species 0.000 claims abstract description 5
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 5
- 235000008434 ginseng Nutrition 0.000 claims abstract description 5
- 230000002478 diastatic effect Effects 0.000 claims abstract description 3
- 239000002893 slag Substances 0.000 claims abstract description 3
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims description 7
- 241000283898 Ovis Species 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 4
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 4
- 240000001008 Dimocarpus longan Species 0.000 claims description 3
- 235000000235 Euphoria longan Nutrition 0.000 claims description 3
- 239000000463 material Substances 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 235000009566 rice Nutrition 0.000 abstract description 3
- 235000013339 cereals Nutrition 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 241000405414 Rehmannia Species 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- NPDAQZUAWDTCIZ-YJCQVRHNSA-N (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[[7-[2-hydroxy-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]-1,1,4a,7-tetramethyl-3,4,4b,5,6,9,10,10a-octahydro-2h-phenanthren-2-yl]oxy]oxane-3,4,5-triol Chemical compound C1=C2CCC3C(C)(C)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CCC3(C)C2CCC1(C)C(CO)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPDAQZUAWDTCIZ-YJCQVRHNSA-N 0.000 abstract 1
- 241000427159 Achyranthes Species 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 244000003416 Asparagus officinalis Species 0.000 abstract 1
- 235000005340 Asparagus officinalis Nutrition 0.000 abstract 1
- 241000950640 Calcarius Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000241463 Cullen corylifolium Species 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- NPDAQZUAWDTCIZ-UHFFFAOYSA-N Neodarutoside Natural products C1=C2CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CCC1(C)C(CO)OC1OC(CO)C(O)C(O)C1O NPDAQZUAWDTCIZ-UHFFFAOYSA-N 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 19
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- 239000000341 volatile oil Substances 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical compound C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 230000001077 hypotensive effect Effects 0.000 description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 2
- OIGWAXDAPKFNCQ-UHFFFAOYSA-N 4-isopropylbenzyl alcohol Chemical compound CC(C)C1=CC=C(CO)C=C1 OIGWAXDAPKFNCQ-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 2
- AKGGYBADQZYZPD-UHFFFAOYSA-N benzylacetone Chemical compound CC(=O)CCC1=CC=CC=C1 AKGGYBADQZYZPD-UHFFFAOYSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 229940025250 camphora Drugs 0.000 description 2
- 239000010238 camphora Substances 0.000 description 2
- RGIBXDHONMXTLI-UHFFFAOYSA-N chavicol Chemical compound OC1=CC=C(CC=C)C=C1 RGIBXDHONMXTLI-UHFFFAOYSA-N 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 229940087305 limonene Drugs 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- -1 methyl salicylic aldehyde Chemical compound 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WMBOCUXXNSOQHM-FLIBITNWSA-N (Z)-3-butylidenephthalide Chemical compound C1=CC=C2C(=C/CCC)/OC(=O)C2=C1 WMBOCUXXNSOQHM-FLIBITNWSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- ICWHTQRTTHCUHW-IPYPFGDCSA-N 2-[(3s,5r,6r)-6,10-dimethylspiro[4.5]dec-9-en-3-yl]propan-2-ol Chemical compound C[C@@H]1CCC=C(C)[C@]11C[C@@H](C(C)(C)O)CC1 ICWHTQRTTHCUHW-IPYPFGDCSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- VNFYMAPAENTMMO-UHFFFAOYSA-N 5-chloro-2-methylquinoline Chemical compound ClC1=CC=CC2=NC(C)=CC=C21 VNFYMAPAENTMMO-UHFFFAOYSA-N 0.000 description 1
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- ICWHTQRTTHCUHW-UHFFFAOYSA-N Agarospirol Natural products CC1CCC=C(C)C11CC(C(C)(C)O)CC1 ICWHTQRTTHCUHW-UHFFFAOYSA-N 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- JXRNMQDTJAQLAQ-UTZXOHNXSA-N Aplotaxene Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCC=C JXRNMQDTJAQLAQ-UTZXOHNXSA-N 0.000 description 1
- ZFSOYHNWYLNZIP-UHFFFAOYSA-N Aplotaxene Natural products CCC=CCC=CC=CCCCCCCC=C ZFSOYHNWYLNZIP-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- GLZOMALSMBXHLS-UHFFFAOYSA-N COC(C(C)=O)(CC1=CC=CC=C1)CC1=CC=CC=C1 Chemical compound COC(C(C)=O)(CC1=CC=CC=C1)CC1=CC=CC=C1 GLZOMALSMBXHLS-UHFFFAOYSA-N 0.000 description 1
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 1
- 241000208809 Carthamus Species 0.000 description 1
- QIIDATRCGITYRZ-UHFFFAOYSA-N Catalpol Natural products OCC1OC(OC2OC=CC3C(O)C(=C(CO)C23)O)C(O)C(O)C1O QIIDATRCGITYRZ-UHFFFAOYSA-N 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- IAZKGRRJAULWNS-UHFFFAOYSA-N Chavicol Natural products OC1=CC=C(CCC=C)C=C1 IAZKGRRJAULWNS-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000000899 Gutta-Percha Substances 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- JXRNMQDTJAQLAQ-UHFFFAOYSA-N Heptadecatetraen Natural products CCC=CCC=CCC=CCCCCCC=C JXRNMQDTJAQLAQ-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 240000000342 Palaquium gutta Species 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical group C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- 229940008075 allyl sulfide Drugs 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- IPZIYGAXCZTOMH-UHFFFAOYSA-N alpha-eudesmol Natural products CC1=CCCC2CCC(CC12)C(C)(C)O IPZIYGAXCZTOMH-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002223 anti-pathogen Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000003005 anti-senility effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical group OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- MBZBBVTYLUNZPJ-UHFFFAOYSA-N beta-caryophyllene ketone Natural products C1CC(C)=CCCC(=O)C2CC(C)(C)C21 MBZBBVTYLUNZPJ-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- LHDWRKICQLTVDL-PZYDOOQISA-N catalpol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2[C@@]3(CO)O[C@H]3[C@@H](O)[C@@H]2C=CO1 LHDWRKICQLTVDL-PZYDOOQISA-N 0.000 description 1
- UXSACQOOWZMGSE-UHFFFAOYSA-N catalposide Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(OC(=O)C=3C=CC(O)=CC=3)C2C=CO1 UXSACQOOWZMGSE-UHFFFAOYSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- IFYYFLINQYPWGJ-UHFFFAOYSA-N gamma-decalactone Chemical compound CCCCCCC1CCC(=O)O1 IFYYFLINQYPWGJ-UHFFFAOYSA-N 0.000 description 1
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229920000588 gutta-percha Polymers 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- LHDWRKICQLTVDL-UHFFFAOYSA-N methyl iridoid glycoside Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(O)C2C=CO1 LHDWRKICQLTVDL-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- WMBOCUXXNSOQHM-UHFFFAOYSA-N n-butylidenephthalide Natural products C1=CC=C2C(=CCCC)OC(=O)C2=C1 WMBOCUXXNSOQHM-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 1
- 230000001354 painful effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 230000026676 system process Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 229930006978 terpinene Natural products 0.000 description 1
- 150000003507 terpinene derivatives Chemical class 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a method for preparing health care macrobiosis wine. The present invention is characterized in that traditional Chinese medicine of 300 to 700g of safflower, 100 to 600g of longspur epimedium, 250 to 680g of mutton fat, 60 to 300g of angelica, 20 to 80g of desertliving cistanche, 15 to 150g of twotooth achyranthes root, 100 to 500g of slenderstyle acanthopanax bark, 160 to 380g of wolfberry bark, 32 to 66g of eucommia bark, 10 to 90g of cochinchnese asparagus root, 10 to 70g of malaytea scurfpea fruit, 100 to 350g of tuckahoe, 10 to 48g of costustoot, 36 to 180g of adhesive rehmannia dried root, 100 to 300g of prepared rehmannia root, 5 to 40g of flos caryophyllata, 100 to 250g of ginseng, 300 to 900g of neodarutoside and other auxiliary medicinal materials are mixed with 50kg of glutinous rice. The medicinal materials are pulverized into powder, and then, the medicinal material powder is mixed with the glutinous rice with wine medicine and is arranged into a jar fermenter for saccharification to finish primary fermentation; next, after the completion of the diastatic fermentation, grain wine with high alcoholicity is mixed with the materials to complete secondary fermentation; afterwards, pit storage is carried out after the slag removal treatment; finally, the overall process for manufacturing the health care macrobiosis wine is finished.
Description
Technical field
The present invention relates to a kind of preparation of health care fermented wine, belong to the compound method class of Chinese medicine health-care beverage.
Background technology
Along with the development of contemporary science and technology, human understanding to self has had new progress, thinks that people's the theoretical life-span can reach more than 140 years old, and these are that to be based upon munificent day by day material progress life and spiritual civilization in life certainly.But the real-life mankind, its average life is well below theoretical value, and its main cause is the quickening of contemporary mankind along with work, rhythm of life, and human body constitution and physical ability more and more will be in the face of the multiple pressure that runs in the work life.Because the fast running of over loading, because the infringement that multiple environmental pollution brings, many modern humans are in sub-health state or senilism phenomenon, and the performance of these human body senilism phenomenons is mainly aspect following; The age of hypertension, people with hyperlipidemia reduces, and number increases, the lumbago that expression human body renal function goes down, frequent micturition, tinnitus, alopecia ... focus appear among the above-mentioned crowd all the more morely; Certainly, along with the increase of aged tendency of population phenomenon, last time, aging phenomenon also was the problem that vast aged crowd faces.
Therefore, for the modern humans provides a kind of product of healthy and anti-senility or method has been the heat subject that numerous research units and health product manufacturer extremely are concerned about, the inventor wants the Chinese medicine civilization of utilizing China long, and a kind of body building liquor and compound method thereof of life lengthening is provided.
Technology contents
The compound method of this Chinese medicine health care wine, it is characterized in that: its warp is to comprise following three steps, at first be with Chinese crude drug Flos Carthami 300-700g, Herba Epimedii 100-600g, Adeps caprae seu ovis 250-680g, Radix Angelicae Sinensis 60-300g, Herba Cistanches 20-80g, Radix Achyranthis Bidentatae 15-150g, Cortex Acanthopancis 100-500g, Cortex Lycii 160-380g, Cortex Eucommiae 32-66g, Radix Asparagi 10-90g, Fructus Psoraleae 10-70g, Poria 100-350g, Radix Aucklandiae 10-48g, Radix Rehmanniae 36-180g, Radix Rehmanniae Preparata 100-300g, Flos Caryophylli 5-40g, Radix Ginseng 100-250g Herba Siegesbeckiae 300-900g is ground into powdery, mix in the 50Kg Oryza glutinosa, mix and put into jar fermenter together and carry out saccharifying, finish fermentation for the first time; It two is to mix the height grain wine again to finish fermentation for the second time by it after its diastatic fermentation is finished; It three is to store sth. in a cellar after slag is handled through taking off.
Also have in the Chinese crude drug: Pericarpium Zanthoxyli 10-65g, Flos Chrysanthemi 38-80g, Radix Glycyrrhizae 38-60g, Rhizoma Atractylodis 120-270g, Radix Paeoniae Alba 30-70g, Fructus Amomi 8-40g, Radix Aucklandiae 10-50g, Fructus Amomi Rotundus 25-70g, Radix Aconiti Lateralis Preparata 10-30g, Lignum Aquilariae Resinatum 10-40g, Fructus Jujubae 1200-4000g, Rhizoma Atractylodis Macrocephalae 100-300g, very light blue 100-400g, longan 500-1000g, Flos Osmanthi Fragrantis 120-200g.
Health care wine according to above prescription and processing technology preparation, because the Chinese crude drug that it adopted has taken into full account the human body negative and positive and has coordinated, pass through biochemical fermentation simultaneously, make various active ingredients in the medical material participate in biochemical reaction in the fermented glutinous rice system process, thereby make this drinking utensils that blood circulation promoting and blood stasis dispelling be arranged, defeated through effects such as collateral dredging, Yang nourishing-strengthenings.
The specific embodiment
Below provide embodiments of the invention.
| Component | Embodiment 1 | Embodiment 2 | Embodiment 3 |
| Flos Carthami | 300g | 500g | 700g |
| Herba Epimedii | 100g | 350g | 600g |
| Adeps caprae seu ovis | 250g | 465g | 680g |
| Radix Angelicae Sinensis | 60g | 180g | 300g |
| Herba Cistanches | 20g | 50g | 80g |
| Radix Achyranthis Bidentatae | 15g | 82.5g | 150g |
| Cortex Acanthopancis | 100g | 300g | 500g |
| Cortex Lycii | 160g | 270g | 380g |
| The Cortex Eucommiae | 32g | 49g | 66g |
| Radix Asparagi | 10g | 50g | 90g |
| Fructus Psoraleae | 10g | 40g | 70g |
| Poria | 100g | 225g | 350g |
| The Radix Aucklandiae | 10g | 29g | 48g |
| Radix Rehmanniae | 36g | 108g | 180g |
| Radix Rehmanniae Preparata | 100g | 200g | 300g |
| Flos Caryophylli | 5g | 22.5g | 40g |
| Radix Ginseng | 100g | 175g | 250g |
| Herba Siegesbeckiae | 300g | 600g | 900g |
| Pericarpium Zanthoxyli | 10g | 37.5g | 65g |
| Flos Chrysanthemi | 38g | 59g | 80g |
| Radix Glycyrrhizae | 38g | 49g | 60g |
| Rhizoma Atractylodis | 120g | 195g | 270g |
| Radix Paeoniae Alba | 30g | 50g | 70g |
| Fructus Amomi | 8g | 24g | 40g |
| The Radix Aucklandiae | 10g | 30g | 50g |
| Fructus Amomi Rotundus | 25g | 47.5g | 70g |
| Radix Aconiti Lateralis Preparata | 10g | 20g | 30g |
| Lignum Aquilariae Resinatum | 10g | 25g | 40g |
| Fructus Jujubae | 1200g | 2600g | 4000g |
| The Rhizoma Atractylodis Macrocephalae | 100g | 200g | 300g |
| Very light blue | 100g | 250g | 400g |
| Longan | 500g | 750g | 1000g |
| Flos Osmanthi Fragrantis | 120g | 160g | 200g |
Why this health care wine has good health-improving, mainly is because above-mentioned Chinese crude drug has following effect respectively.
Flos Carthami: be rich in Carthamus yellow and carthamin, also contain safflower oil in addition, leaf contains glycoside, has promoting blood circulation to restore menstrual flow, blood stasis removing pain-relieving functions.
Herba Epimedii: contain the Herba Epimedii glycoside, the tool kidney invigorating and YANG supporting, expelling wind and removing dampness, anxious to the muscles and bones contraction, hemiplegia, weakness of the waist and knees, rheumatic arthralgia is powerful.
Adeps caprae seu ovis: contain satisfied fatty acid, the tool tonify deficiency, moisturize, dispel the wind, the removing toxic substances effect, control asthenia and win thin.
Radix Angelicae Sinensis: contain butylidenephthalide, positive pentanone of adjacent carboxyl benzene and dihydro acid phthalic anhydride, vitamin B12, tool benefiting blood and regulating blood circulation, functions such as regulating menstruation, hemostasis.
Herba Cistanches: contain micro-alkaloid and crystallinity neutral substance, the tool the kidney invigorating and essence nourishing is moisturized function.
Radix Achyranthis Bidentatae: root contains triterpenoid saponin, and contains volume first salt, and other contains ecdysterone, gives birth to the dissipating blood stasis hemostasis, and the pain that disappears is swollen, ripely use invigorating the liver and kidney, bone and muscle strengthening, and the tool lid is smart, Li Yin gas, only poliosis effect.
Cortex Acanthopancis: root contains methyl salicylic aldehyde etc. and tannin, Palmic acid, linolenic acid and vitamin A, B; Tool wind-damp dispelling, shape muscles and bones, blood circulation invigorating efficacies.
Cortex Lycii: contain cinnamic acid and volume aldehydes matter, betanin and suppress the thiamine active matter, the effect of tool clearing away heat and cooling blood has hypotensive effect to cardiovascular system, and again can blood sugar lowering.
Pericarpium Zanthoxyli: contain volatile oil, contain male geraniol, limonene, cumic alcohol in this oil, tool main air pathogen is removed arthralgia due to cold, the hard tooth and hair effect that makes eye bright.
The Cortex Eucommiae: contain gutta-percha and glucoside, alkaloid, pectin saccharon, tool invigorating the liver and kidney, bone and muscle strengthening effect.
Radix Asparagi: contain asparagine, phlegmatic temperament, β-paddy steroid soap alcohol and 5-methoxy bran aldehyde; The tool antibacterial and anti-inflammation functions, can YIN nourishing, moisturize, the effect of lung heat clearing pathogenic fire reducing.
Fructus Psoraleae: contain volatile oil, its composition is organic acid C
40H
45O
10, methyl glucoside, alkali soluble resins, fixedness terpenoid oil, Saponin etc.; The tool antibacterial action, the tool reinforcing the kidney and supporting YANG.
Flos Chrysanthemi: contain volatile oil, and have adenine, choline, stachydrine, aminoacid and trace to give living plain B
1, have the antipathogen effect, have dispelling wind, clearing away heat to improve acuity of vision, Detoxication.
Poria: its sclerotium contains β-pachyman and triterpenoid compound acetyl pachymic acid, beta-hydroxy Pilus Caprae seu Ovis steroid trienic acid and chitin, protein, lecithin etc. and has effects such as diuresis, antibiotic and blood sugar lowering.
Rhizoma Atractylodis: contain volatile oil, hypoglycemic activity is arranged, have the spleen strengthening and damp drying, resolving depression, ward off dirty effect based on atractylol, atractylone, hinesol and eudesmol.
Radix Paeoniae Alba: contain paeoniflorin, paeonol, paeoniflorin, volatile oil, cupreol and triterpenes, pain relieving during the tool nourishing blood to suppress the hyperactive liver is slow, yin fluid astringing is received the effect of antiperspirant; Staphylococcus aureus there is inhibitory action.
Fructus Amomi: contain volatile oil, it mainly is grown up and is d-Camphora, d-Borneolum Syntheticum, and limonene is during the tool circulation of qi promoting is transferred, the stomach function regulating effect of being amusing.
The Radix Aucklandiae: contain aplotaxene, α-Zi Luolantong, constuslactone etc., the tool promoting the circulation of QI to relieve pain, warming middle-JIAO for easing the stomach, and separate painful and hypotensive effect, antibacterial action is also arranged simultaneously.
Fructus Amomi Rotundus: containing volatile oil mainly is d-Borneolum Syntheticum, d-Camphora, and cineole and terpinene, pinene have circulation of qi promoting, and warming the stomach helps digestion, the effect of alleviating distention in middle-JIAO.
Radix Rehmanniae: contain β-each sterol and mannitol and a small amount of stigmasterol, also contain rehmanin alkaloid, fatty acid, catalpol; The tool YIN nourishing, nourish blood, have function of blood sugar reduction.
Radix Rehmanniae Preparata: little sweet, tepor, tool nourishing YIN and supplementing blood, the deficiency of YIN of living insufficiency of blood, waist knee flaccidity.
Radix Aconiti Lateralis Preparata: contain multiple biology, heart tonifying and hypotensive effect are arranged.The tool recuperating depleted YANG is mended fire, dispelling cold and removing dampness effect.
Flos Caryophylli: contain evaporable Oleum Caryophylli, contain eugenol, β-caryophyllene and methyl-n-amyl ketone in this oil, methyl salicylate, chavicol etc., have antibiotic, anthelmintic, effect such as be good for the stomach, tool warming the kidney, sending down the abnormal ascending QI effect simultaneously.
Radix Ginseng: contain the ginsenoside, multiple glucose and multiple triterpenoid, plant sterol, choline, to nerve system of human body, hormonal system, the human body substance metabolism all has the positive impact effect, has strongly invigorating primordial QI, promotes the production of body fluid and sedative action admittedly take off.
Lignum Aquilariae Resinatum: contain benzylacetone in the volatile oil, to the methoxybenzyl benzylacetone, linalool etc. have the sending down the abnormal ascending QI warming middle-JIAO, the effect of warming the kidney improving inspiration by invigorating kidney-QI.
Fructus Jujubae: fruit contains protein, saccharide, organic acid, phlegmatic temperament, vitamin A, B
2, C, the micro-calcium ferrophosphorus has the spleen reinforcing stomach function regulating, supplementing QI for promoting the production of body fluid transfers battalion to separate the poison of drug effect.
The Rhizoma Atractylodis Macrocephalae: contain volatile oil, Main Ingredients and Appearance is an atractylol, atractylone and vitamin A, diuresis, hypoglycemic activity is arranged.
Very light blue: contain volatile oil in the bulb, Main Ingredients and Appearance is allicin and allyl sulfide, multivitamin, tool deliver activate yang, Detoxication.
Herba Siegesbeckiae: contain You darutin-bitter and alkaloid, tool antiinflammatory, hypotensive effect.
Flos Osmanthi Fragrantis: contain aromatic substance decanolactone, α-Zi Luolantong, β-tools such as water ketone alkene reduce phlegm, the dissipating blood stasis effect.
Claims (2)
1, a kind of compound method of Chinese medicine health care wine, it is characterized in that: it comprises following three steps, at first be with medium square Flos Carthami 300-700g, Herba Epimedii 100-600g, Adeps caprae seu ovis 250-680g, Radix Angelicae Sinensis 60-300g, Herba Cistanches 20-80g, Radix Achyranthis Bidentatae 15-150g, Cortex Acanthopancis 100-500g, Cortex Lycii 160-380g, Cortex Eucommiae 32-66g, Radix Asparagi 10-90g, Fructus Psoraleae 10-70g, Poria 100-350g, Radix Aucklandiae 10-48g, Radix Rehmanniae 36-180g, Radix Rehmanniae Preparata 100-300g, Flos Caryophylli 5-40g, Radix Ginseng 100-250g and Herba Siegesbeckiae 300-900g are ground into powdery, mix in the 50Kg Oryza glutinosa, mix and put into jar fermenter together and carry out saccharifying, finish fermentation for the first time; It two is to mix the height grain wine again to finish fermentation for the second time by it after its diastatic fermentation is finished; It three is to store sth. in a cellar after slag is handled through taking off.
2, the compound method of a kind of Chinese medicine health care wine as claimed in claim 1 is characterized in that: also have Pericarpium Zanthoxyli 10-65g, Flos Chrysanthemi 38-80g, Radix Glycyrrhizae 38-60g, Rhizoma Atractylodis 120-270g, Radix Paeoniae Alba 30-70g, Fructus Amomi 8-40g, Radix Aucklandiae 10-50g, Fructus Amomi Rotundus 25-70g, Radix Aconiti Lateralis Preparata 10-30g, Lignum Aquilariae Resinatum 10-40g, Fructus Jujubae 1200-4000g, Rhizoma Atractylodis Macrocephalae 100-300g, very light blue 100-400g, longan 500-1000g, Flos Osmanthi Fragrantis 120-200g in the Chinese crude drug.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021398739A CN1208075C (en) | 2002-12-25 | 2002-12-25 | Healthy fermentative wine preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021398739A CN1208075C (en) | 2002-12-25 | 2002-12-25 | Healthy fermentative wine preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1424072A CN1424072A (en) | 2003-06-18 |
| CN1208075C true CN1208075C (en) | 2005-06-29 |
Family
ID=4750259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021398739A Expired - Fee Related CN1208075C (en) | 2002-12-25 | 2002-12-25 | Healthy fermentative wine preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1208075C (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101886030B (en) * | 2010-06-29 | 2012-06-13 | 开封市新天地市政园林有限公司 | Chrysanthemum wine |
| CN101940710B (en) * | 2010-09-13 | 2011-11-09 | 刘铭成 | Health-care wine for regulating sleep and preparation method thereof |
| CN103396921B (en) * | 2013-08-05 | 2014-10-29 | 李竞 | Ginseng pilose-antler wine capable of enhancing immunity and preparation technology thereof |
| CN104164332B (en) * | 2014-07-30 | 2016-01-20 | 樊继绪 | Nourishing the stomach posset and working method thereof |
| CN104544059A (en) * | 2014-12-19 | 2015-04-29 | 赵俊辉 | Formula of nutrient solution for middle and old-aged people and preparation method of nutrient solution |
| CN114058464A (en) * | 2020-08-04 | 2022-02-18 | 汕头市黄姥爷酒业有限责任公司 | Wuzi Yanzong wine and preparation method thereof |
| CN113209243A (en) * | 2020-08-11 | 2021-08-06 | 湖南长彤生物科技有限责任公司 | Wine, preparation method and application |
-
2002
- 2002-12-25 CN CNB021398739A patent/CN1208075C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1424072A (en) | 2003-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1172674A (en) | Chinese medicinal herb composition for treating skin disease | |
| CN103142812B (en) | Traditional Chinese medicine for preventing and treating alcoholic liver injury and preparation method of traditional Chinese medicine | |
| CN102512632B (en) | Chinese herbal composition for treating abnormal menstruation | |
| CN1208075C (en) | Healthy fermentative wine preparation | |
| CN107715014A (en) | A kind of Chinese medicine composition for gout and preparation method thereof | |
| CN103638475B (en) | A kind of medicinal herb spray for the treatment of nodules of the breast and preparation method thereof | |
| CN101156920B (en) | Oral administration and externally used drug for treating traumatic injury and its preparation method | |
| CN1077789C (en) | Bathing preparation and making method thereof | |
| CN104706999A (en) | Traditional Chinese medicinal composition for regulating cardiovascular and cerebrovascular diseases and preparation method of traditional Chinese medicinal composition | |
| CN104324310B (en) | It is a kind of to be used to treat Chinese medicine composition of fungal keratitis and preparation method thereof after immunosupress | |
| CN101057922A (en) | Traditional Chinese medicine preparation for treating vitiligo | |
| CN102895610A (en) | Medicine for treating edema | |
| CN1238020C (en) | Medicine for treating waist and lower extremities pain | |
| CN104474129A (en) | Medicinal formula for treating coronary heart disease and use method thereof | |
| CN116492428A (en) | A Chinese medicinal composition for preventing and treating cardiovascular and cerebrovascular diseases | |
| CN103520644B (en) | Traditional Chinese medicine composition used for treating phlegm stagnation type hyperlipidaemia and preparation method of composition | |
| CN1319586C (en) | Medicinal composition for treating brain apoplexy | |
| CN101987188B (en) | Biological Chinese patent medicine for preventing and treating hyperlipidemia | |
| CN1299715C (en) | Preparing tablets of reducing blood fat | |
| CN101279031A (en) | Chinese medicinal composition for curing hyperthyroidism and method of preparing the same | |
| CN1308020C (en) | Traditional Chinese medicine composition for treating psoriasis | |
| CN1203799A (en) | Compound quick-acting hypotensive medicine and its preparation method | |
| CN1634534A (en) | Anti-senescence bee medicine health care preparation | |
| CN1309412C (en) | Medicine composition for treating AIDS and preparing method thereof | |
| CN1685972A (en) | Antisenility health care food |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |